Cargando…

CLL und Covid-19

Detalles Bibliográficos
Autor principal:	Behrend, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Medizin 2022
Materias:	Hämatologie
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979643/ http://dx.doi.org/10.1007/s15015-022-3802-6

Ejemplares similares

Schlechte Impfantwort bei CLL-Patienten
por: Behrend, Christian
Publicado: (2021)

CLL: Mortalität bei Erkrankung an COVID-19 gesunken
por: von Kieseritzky, Kathrin
Publicado: (2023)

Impfen und Prophylaxen bei Myelompatienten
por: Berger, Doris
Publicado: (2022)

Thrombopenie auf der Intensivstation: Diagnose, Differenzialdiagnose und Therapie
por: Knöbl, Paul
Publicado: (2017)

Multiples Myelom in der COVID-19-Pandemie
por: von Kieseritzky, Kathrin
Publicado: (2021)

Anti-CD20-Antikörpertherapie ist keine Kontraindikation für COVID-19-Impfung!
por: Wendtner, Clemens-Martin
Publicado: (2021)

Versorgung von Myelompatienten in der Pandemie: Individuelle Abwägung ist gefragt
por: Klein, Friederike
Publicado: (2021)

Schlechte Impfantwort bei CLL-Patienten
por: Behrend, Christian
Publicado: (2021)

CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL?
por: Popov, Viola, et al.
Publicado: (2022)

Poster: CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL?
por: Popov, Viola, et al.
Publicado: (2022)

CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022)

When CLL meets COVID-19
por: Montserrat, Emili
Publicado: (2020)

Vaccinations in CLL: implications for COVID-19
por: Shadman, Mazyar, et al.
Publicado: (2021)

Immediate COVID-19 treatment in CLL
por: Niemann, Carsten Utoft
Publicado: (2023)

Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022)

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
por: Chatzikonstantinou, Thomas, et al.
Publicado: (2021)

CLL and COVID-19: light at the end of the tunnel?
por: Scarfò, Lydia, et al.
Publicado: (2022)

Efficacy of COVID-19 vaccine in patients with CLL
Publicado: (2021)

Worldwide Examination of Patients with CLL Hospitalized for COVID-19
por: Roeker, Lindsey E, et al.
Publicado: (2020)

Vaccination against COVID-19: a challenge in CLL
por: Eichhorst, Barbara
Publicado: (2021)

Covid-19: Schutzmaßnahmen in onkologischen Einrichtungen
por: Behrend, Christian
Publicado: (2021)

CLL-IPI applied in Binet A CLL: a nationwide cohort study
por: Rotbain, Emelie C., et al.
Publicado: (2022)

Metaanalyse zum Nutzen von Tocilizumab bei COVID-19
por: Behrend, Christian
Publicado: (2021)

CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report
por: Baumann, Tycho, et al.
Publicado: (2020)

Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL
por: Sun, Clare, et al.
Publicado: (2021)

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel
por: Yekutiel, Naama, et al.
Publicado: (2023)

Outcomes of COVID-19 in patients with CLL: a multicenter international experience
por: Mato, Anthony R., et al.
Publicado: (2020)

COVID-19 in patients with CLL: how can we change the odds?
por: Herishanu, Yair, et al.
Publicado: (2021)

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
por: Scarfò, Lydia, et al.
Publicado: (2020)

Leptomeningeal involvement in CLL
por: Chantepie, Sylvain P., et al.
Publicado: (2014)

Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data
por: Parviz, Mehdi, et al.
Publicado: (2022)

Not all lymphoid aggregates in chronic lymphocytic leukemia (CLL) patients are due to CLL!
por: Mahapatra, Lily, et al.
Publicado: (2021)

Asthma und Covid-19
por: Buhl, Roland, et al.
Publicado: (2020)

Patients with CLL have a lower risk of death from COVID-19 in the Omicron era
por: Niemann, Carsten U., et al.
Publicado: (2022)

The Outcomes of Covid-19 in Patients with CLL during the Omicron Sub-Variants Surge
por: Bronstein, Yotam, et al.
Publicado: (2022)

COVID-19 among fit patients with CLL treated with venetoclax-based combinations
por: Fürstenau, Moritz, et al.
Publicado: (2020)

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
por: Roeker, Lindsey E., et al.
Publicado: (2021)

Analysis of immune responses in patients with CLL after heterologous COVID-19 vaccination
por: Lee, Hye Kyung, et al.
Publicado: (2023)

Significance of t (8: 14) in CLL?
por: Lakshmaiah, K. C., et al.
Publicado: (2010)

CLL kinetics in the tumor microenvironment
por: Sun, Clare, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_egae8v8g2v1u3o67o3mkvn6tib